|

|
This program is sponsored by Northwestern University Medical School Office of
Continuing Medical Education.
Conference Focus
The focus of HIV DART 2000 is to assemble clinicians, researchers
and basic scientists together to advance our knowledge of the ongoing drug
development processes in antiretroviral research. HIV DART 2000 will uniquely
blend the areas of biology, chemistry, pharmacology and clinical research to
provide the scientific community an increased understanding of the current and
future challenges in therapeutics for HIV infection.
Conference Program Highlights
-
Opening session will comprise a presentation by Dr. Anthony Fauci, NIAID,
National Institutes of Health on Sunday, December 17, 2000 at 2:00 PM
-
Satellite symposia will follow the Opening Session
-
Scientific sessions commence at 8:00 AM on Monday, December 18, 2000
-
The conference program includes sessions covering the following topics:
-
Drug Design and Discovery: Viral Targets
-
Chemistry and Pre-Clinical Development
-
Viral Resistance
-
Phenotypic and Genotypic Assays
-
Pharmacology
-
Immunotherapy in HIV Infection
-
First-line and Salvage Therapy
-
Treatment Failure and Drug Interactions
-
Pediatrics
-
HIV/Hepatitis and Other Co-infections
-
Vaccines/Therapeutic Vaccines
Important Dates
| Conference dates |
December 17-21, 2000 |
| Early registration deadline |
September 29, 2000 |
| Abstract submission deadline |
November 6, 2000 |
| Abstract acceptance notification |
November 20, 2000 |
| Final date for registration |
December 4, 2000 |
| Opening session at 2:00 PM |
December 17, 2000 |
| Scientific sessions begin at
8:00 AM |
December 18, 2000 |
| Scientific sessions end at 12:30 PM |
December 21, 2000 |
|
| |